Plant ID: NPO2842
Plant Latin Name: Garcinia lucida
Taxonomy Genus: Garcinia
Taxonomy Family: Clusiaceae
NCBI TaxonomyDB:
469933
Plant-of-the-World-Online:
428059-1
Gabon; Congo; Cameroon
TDP1; CBR1; APEX1; | |
CHRNA3; CHRNA4; | |
ALOX5; | |
DPP4; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Enzyme_unclassified | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Enzyme_unclassified | CBR1 | Carbonyl reductase [NADPH] 1 | P16152 | CHEMBL5586 |
Enzyme_unclassified | APEX1 | DNA-(apurinic or apyrimidinic site) lyase | P27695 | CHEMBL5619 |
Nicotinic acetylcholine receptor | CHRNA3 | Neuronal acetylcholine receptor subunit alpha-3 | P32297 | CHEMBL3068 |
Nicotinic acetylcholine receptor | CHRNA4 | Neuronal acetylcholine receptor protein alpha-4 subunit | P43681 | CHEMBL1882 |
Oxidoreductase | ALOX5 | Arachidonate 5-lipoxygenase | P09917 | CHEMBL215 |
Serine protease | DPP4 | Dipeptidyl peptidase IV | P27487 | CHEMBL284 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0007610; behavior | GO:0035095; behavioral response to nicotine | 2.362E-06 | 5.143E-02 | CHRNA3, CHRNA4 |
BP | GO:0007610; behavior | GO:0007626; locomotory behavior | 2.665E-05 | 5.618E-02 | CHRNA3, CHRNA4, DPP4 |
BP | GO:0050896; response to stimulus | GO:0095500; acetylcholine receptor signaling pathway | 2.838E-05 | 5.618E-02 | CHRNA3, CHRNA4 |
MF | GO:0060089; molecular transducer activity | GO:0015464; acetylcholine receptor activity | 1.718E-05 | 5.618E-02 | CHRNA3, CHRNA4 |
BP | GO:0023052; signaling | GO:0007271; synaptic transmission, cholinergic | 3.934E-05 | 6.119E-02 | CHRNA3, CHRNA4 |
BP | GO:0023052; signaling | GO:0060079; excitatory postsynaptic potential | 2.611E-04 | 2.630E-01 | CHRNA3, CHRNA4 |
CC | GO:0044456; synapse part | GO:0045211; postsynaptic membrane | 2.406E-03 | 7.175E-01 | CHRNA3, CHRNA4 |
CC | GO:0044464; cell part | GO:0005641; nuclear envelope lumen | 2.896E-03 | 7.507E-01 | ALOX5 |
CC | GO:0016020; membrane | GO:0098857; membrane microdomain | 4.640E-03 | 9.262E-01 | CHRNA3, DPP4 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 1.966E-04 | 2.359E-03 | CBR1, ALOX5 |
09150 Organismal Systems | 09156 Nervous system | hsa04725 | Cholinergic synapse | 6.295E-04 | 3.777E-03 | CHRNA3, CHRNA4 |
09130 Environmental Information Processing | 09133 Signaling molecules and interaction | hsa04080 | Neuroactive ligand-receptor interaction | 3.834E-03 | 1.533E-02 | CHRNA3, CHRNA4 |
09150 Organismal Systems | 09152 Endocrine system | hsa04913 | Ovarian steroidogenesis | 1.737E-02 | 3.474E-02 | ALOX5 |
09160 Human Diseases | 09164 Substance dependence | hsa05033 | Nicotine addiction | 1.392E-02 | 3.340E-02 | CHRNA4 |
09120 Genetic Information Processing | 09124 Replication and repair | hsa03410 | Base excision repair | 1.149E-02 | 3.340E-02 | APEX1 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 2.528E-02 | 4.144E-02 | CBR1 |
09160 Human Diseases | 09167 Infectious diseases | hsa05145 | Toxoplasmosis | 4.058E-02 | 4.427E-02 | ALOX5 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 2.835E-02 | 4.144E-02 | CBR1 |
09150 Organismal Systems | 09154 Digestive system | hsa04974 | Protein digestion and absorption | 3.108E-02 | 4.144E-02 | DPP4 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Drug abuse | F10-F19 | CHRNA3; |
R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified | Cough | R05 | CHRNA3; |